⌘K

Login Start Free

Home/Filings/4/0001824293-25-000117

4//SEC Filing

Rongen Roelof 4

Accession 0001824293-25-000117

CIK 0001824293other

View on SEC.gov Company Profile

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 4:58 PM ET

Size

5.5 KB

Accession

0001824293-25-000117

Insider Transaction Report

Form 4

Period: 2025-08-13

GRI Bio, Inc.GRI

Director

Transactions

Award
Stock Option (Right to Buy)
2025-08-13+4,527→ 4,527 total
Exercise: $1.30Exp: 2035-08-13→ Common Stock (4,527 underlying)

Footnotes (1)

[F1]The stock option vests in 4 equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant.

Documents

1 file

4
wk-form4_1755205102.xmlPrimary
FORM 4

Issuer

GRI Bio, Inc.

CIK 0001824293

Entity typeother

Related Parties

1

filerCIK 0001698966

Filing Metadata

Form type: 4
Filed: Aug 13, 8:00 PM ET
Accepted: Aug 14, 4:58 PM ET
Size: 5.5 KB

View on SEC.gov